Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study.
carotid plaque
prospective study
rheumatoid arthritis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Oct 2021
27 Oct 2021
Historique:
received:
12
09
2021
revised:
24
10
2021
accepted:
25
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
14
11
2021
Statut:
epublish
Résumé
Patients with rheumatoid arthritis (RA) have a higher incidence of subclinical atherosclerosis and cardiovascular (CV) disease. It is postulated that the appearance of accelerated atherosclerosis in these patients is a consequence of the inflammation present in the disease. In this study, we aim to determine if baseline disease activity in patients with RA predicts the future development of carotid plaque. A set of consecutive RA patients without a history of CV events, cancer or chronic kidney disease, who did not show carotid plaque in a carotid ultrasound assessment, were prospectively followed up for at least 5 years. At the time of recruitment, CV risk factors and disease-related data, including disease activity scores, were assessed. At the end of the follow-up, a carotid ultrasound was repeated and patients were divided into two groups; those who developed carotid plaque, and those who did not. A multivariable regression analysis was performed to define the predictors for the development of carotid plaque. One hundred and sixty patients with RA were followed up for an average of 6 ± 1 years. After this time, 66 (41%) of the patients had developed carotid plaque, and 94 (59%) did not. Patients with carotid plaque were significantly older (47 ± 13 vs. 55 ± 9 years,
Identifiants
pubmed: 34768495
pii: jcm10214975
doi: 10.3390/jcm10214975
pmc: PMC8585072
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI18/00043
Références
Ann Rheum Dis. 2015 Apr;74(4):668-74
pubmed: 24389293
Ann Rheum Dis. 2010 Nov;69(11):1920-5
pubmed: 20444756
Arthritis Rheum. 2007 Feb 15;57(1):125-32
pubmed: 17266100
Arthritis Rheum. 2001 Dec;44(12):2737-45
pubmed: 11762933
Arthritis Rheum. 2005 Sep;52(9):2625-36
pubmed: 16142705
Semin Arthritis Rheum. 2020 Dec;50(6):1333-1338
pubmed: 32416998
Autoimmun Rev. 2016 Nov;15(11):1013-1030
pubmed: 27490206
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Best Pract Res Clin Rheumatol. 2016 Oct;30(5):851-869
pubmed: 27964792
Arthritis Care Res (Hoboken). 2011 Apr;63(4):522-9
pubmed: 20957658
Arthritis Rheum. 2008 Dec 15;59(12):1690-7
pubmed: 19035419
Ann Rheum Dis. 2015 Jun;74(6):998-1003
pubmed: 24458537
Cerebrovasc Dis. 2007;23(1):75-80
pubmed: 17108679
Arthritis Rheumatol. 2015 Jun;67(6):1449-55
pubmed: 25776112
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
J Rheumatol. 2005 Jul;32(7):1219-23
pubmed: 15996055
Ann Rheum Dis. 2014 Apr;73(4):722-7
pubmed: 23505241